Samrat Pharmachem Ltd.

BSE: SAMRATPH530125ISIN INE103E01016

Healthcare
Pharmaceuticals

BSE listing

Share price

₹228.95-0.35 (-0.15%)

as of 18 Sep 2026

52W high: ₹333.00
52W low: ₹190.00
Off 52W high: -31.25%
1M return: -3.13%
3M return: +15.19%
6M return: +8.10%
1Y return: -28.45%
20D avg volume: 818
50 DMA: ₹241.84
200 DMA: ₹225.51

Key ratios Standalone

Market cap: ₹70.74 Cr
Current price: ₹228.95
52W high / low: ₹333.00 / ₹190.00
Face value: ₹10.00
P/E: -32.07
P/B: 1.02
EPS (TTM): ₹-7.14
Book value / share: ₹224.46
ROE: -3.18%
ROCE: -2.90%
Operating margin: 2.37%
Net margin: 1.10%
Debt / equity: 0.16
Net debt: ₹4.83 Cr
Interest cover: -2.10
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 65.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	79.76	71.77	63.43	78.87	75.65	71.20	—
	0.99	-0.31	0.40	0.05	0.69	-0.11	—
	79.16	73.34	64.39	79.67	76.14	71.46	—
	78.31	70.38	63.44	73.33	82.52	62.63	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.51	0.69	0.53	0.55	0.51	0.66	—
	0.11	0.14	0.13	0.26	0.44	0.22	—
	0.19	0.19	0.19	0.18	0.17	0.16	—
	1.52	1.60	1.77	1.54	1.63	1.64	—
	1.59	-1.87	-0.57	-0.75	0.21	-0.36	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	1.59	-1.87	-0.57	-0.75	0.21	-0.36	—
	0.71	0.16	-0.11	-0.16	0.44	0.04	—
	0.88	-2.04	-0.46	-0.59	-0.23	-0.40	—
	2.84	-6.59	-1.49	-1.90	-0.74	-1.29	—
Key metrics
	1.89	-1.54	-0.25	-0.31	0.82	0.02	—
	2.40%	-2.10%	-0.40%	-0.40%	1.10%	0.00%	—
	1.10%	-2.80%	-0.70%	-0.70%	-0.30%	-0.60%	—
	—	-2.50%	—	-0.70%	—	-0.20%	—
	5.40%	0.80%	—	—	—	—	—
	482.60%	-410.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	293.83	289.72	285.86	—
	1.13	0.83	0.97	—
	296.56	293.54	276.95	—
	285.46	289.67	269.27	—
	0.00	0.00	0.00	—
	2.28	2.28	2.22	—
	0.64	0.96	0.67	—
	0.75	0.72	0.65	—
	6.43	6.54	6.65	—
	-1.60	-2.98	9.89	—
	0.00	0.00	0.00	—
	-1.60	-2.98	9.89	—
	0.60	0.33	2.77	—
	-2.21	-3.31	7.11	—
	-7.14	-10.72	23.02	—
Key metrics
	-0.21	-1.30	11.21	—
	-0.07%	-0.40%	3.90%	—
	-0.75%	-1.10%	2.50%	—
	—	-2.90%	14.70%	—
	—	1.40%	—	—
	—	-146.60%	—	—
	—	5.80	-10.50	—
	—	-2.68	-1.42	—
	—	0.16	0.14	—
	—	4.83	9.86	—
	—	65.6	71.5	—
Balance sheet
	—	124.42	121.49	—
	—	103.79	103.36	—
	—	5.88	0.05	—
	—	51.05	56.54	—
	—	43.62	38.01	—
	—	—	8.28	—
	—	11.70	10.46	—
	—	42.66	38.56	—
	—	55.82	49.58	—
	—	10.71	9.91	—
	—	10.71	9.91	—
	—	0.00	0.00	—
	—	68.18	71.80	—
Cash flow
	—	8.88	-10.09	—
	—	-2.57	0.00	—
	—	-0.47	0.48	—
	—	3.08	0.41	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 49.09%

Holder	Type	Holding	Previous	Change
LALIT DAMODAR MEHTA	Promoter	13.97%	—	—
RAJESH LALIT MEHTA	Promoter	12.41%	—	—
PREMAL LALIT MEHTA	Promoter Group	5.67%	—	—
KAUSHAL LALIT MEHTA	Promoter Group	4.50%	—	—
JAYA LALIT MEHTA	Promoter Group	3.86%	—	—
SANGEETHA S	Public	3.27%	—	—
RUPAL RAJESH MEHTA	Promoter Group	2.66%	—	—
FALGUNI KAUSHAL MEHTA	Promoter Group	2.15%	—	—
MEGH RAJESH MEHTA	Promoter	1.76%	—	—
KALPANA PREMAL MEHTA	Promoter Group	1.64%	—	—
LALIT KUMAR V JAIN	Public	1.22%	—	—
SHARAD KANAYALAL SHAH	Public	1.13%	—	—
MAITRI MEGH MEHTA	Promoter Group	0.47%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Notice of 34th AGM - Newspaper Publication2 Sep 2026 · Company Update / Newspaper Publication
The Register of Members and Share Transfer books will remain closed from September 20,2026 To September 22, 2026 (both days inclusive)27 Aug 2026 · Corp. Action / Book Closure
34th Annual General Meeting of the company will be held on Wednesday, September 23, 2026 at 1:00 PM (IST) through Video Conferencing (VC) / Other Audio Video Means (OAVM)27 Aug 2026 · AGM/EGM / AGM
34th Annual Report for the Financial Year 2025-2627 Aug 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication of extract of Standalone Unaudited Financial Results for the quarter ended June 30, 2026.19 Aug 2026 · Company Update / Newspaper Publication
The Board considered and adopted the unaudited financial results for the quarter ended June 30, 202614 Aug 2026 · Board Meeting / Outcome of Board Meeting
Appointment of Statutory Auditors for the company from 34th Annual General Meeting to 39th Annual General Meeting17 Jul 2026 · Company Update / Appointment of Statutory Auditor/s
Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th June 202617 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Approval of Un-Audited Financial ....30 Jun 2026 · Board Meeting / Board Meeting
Intimation of Closure of Trading Window for the quarter ended June 30, 202629 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Closure of Trading Window for the quarter ended June 30, 202629 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication of Extract of the Standalone Audited Financial Results for the year ended March 31, 2026.4 Jun 2026 · Company Update / Newspaper Publication
The Board considered and adopted the financial results for the quarter and year ended March 31, 202630 May 2026 · Board Meeting / Outcome of Board Meeting
Audited Financial Results for the quarter and year ended 31st March, 202630 May 2026 · Result / Financial Results
Annual Secretarial Compliance for the year ended 31-March-202630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....7 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Certificate u/r 74(5) for the quarter ended March 31, 20267 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Crisil Limited has upgraded its rating to CRISIL BB/STABLE/ CRISILA4+30 Mar 2026 · Company Update / Credit Rating
Closure of Trading Window from 01-04-2026 till 48 hours after the declaration of Audited Financial Results for the year ended 31/03/202625 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....25 Mar 2026 · Board Meeting / Board Meeting
Newspaper Publication - Extract of Un-audited financial results for the quarter ended 31 December, 202518 Feb 2026 · Company Update / Newspaper Publication
The Board has considered and took on record the Un-audited financial results of the company for the quarter ended December 31, 2025.13 Feb 2026 · Board Meeting / Outcome of Board Meeting
The Board has considered and took on record the un-audited standalone financial results for the quarter ended December 31, 2025.13 Feb 2026 · Result / Financial Results
Certificate u/r 74(5) for the quarter ended 31/12/202512 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Samrat Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the un-audited financial ....29 Dec 2025 · Board Meeting / Board Meeting
The Trading Window of the Company shall remain closed from Thursday, January 1, 2026 till 48 hours after the declaration of Un-audited financial results for the quarter ended December 31, 2025.29 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Crisil Ltd has downgraded its rating to "CrisilBB+/Negative/CrisilA4+"2 Dec 2025 · Company Update / Credit Rating
Newspaper Publication - Extract of Results for the quarter and half year ended September 30, 202520 Nov 2025 · Company Update / Newspaper Publication
Un-audited financial results for the quarter and half year ended 30th September, 202514 Nov 2025 · Result / Financial Results
The Board of Directors considered and took on record the Un-audited Standalone Financial Results for the quarter and half year ended September 30, 2025.14 Nov 2025 · Board Meeting / Outcome of Board Meeting
Certificate under reg. 74(5) for the quarter ended September 30, 202510 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The shareholders approved the dividend on equity shares for the FY: 2024-25 @ Re. 1/- per share of Rs. 10 each (10%)27 Sep 2025 · Corp Action / Dividend/AGM
Scrutinizer Report & Voting Results for 33 AGM27 Sep 2025 · AGM/EGM / AGM
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-audited financial ....26 Sep 2025 · Board Meeting / Board Meeting
Trading Window shall remain closed from 01-10-2025 till 48 hours after the declaration of UFR for the quarter ended September 30, 202526 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
The Company''s 33rd AGM was held today and the business mentioned in the Notice dated July 16, 2025 was transacted.25 Sep 2025 · AGM/EGM / AGM
33rd Annual Report FY: 2024-254 Sep 2025 · Others / Reg. 34 (1) Annual Report
The Register of Members and Share Transfer books will remain closed from September 19, 2025 to September 25, 2025 (both days inclusive)4 Sep 2025 · Corp. Action / Book Closure
The Company has fixed Thursday, September 18, 2025 as the Record Date for determining the members eligibility to receive dividend if approved at the 33rd AGM.4 Sep 2025 · Corp. Action / Record Date
33rd AGM of Samrat Pharmachem Limited is scheduled on Thursday, September 25, 20254 Sep 2025 · AGM/EGM / AGM

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.0000	18 Sep 2025	18 Sep 2025	—
Final Dividend - Rs. - 1.0000	19 Sep 2024	19 Sep 2024	—

Board meetings

14 Aug 2026 Board Meeting - Financial Results